Article
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
11 Mar 2021
Abstract excerpt
BACKGROUND: We sought to determine whether DNA damage response (DDR)-related aberrations predict therapeutic benefit in cisplatin-treated head and neck squamous cell carcinoma (HNSCC) patients and how DDR pathways are modulated after treatment with olaparib alone or in combination with cisplatin or durvalumab. PATIENTS AND METHODS: Oxidative stress, abasic sites and DDR-related parameters, including endogenous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
